These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 17259872)

  • 41. Rapid antibody response after vaccination with a virosomal hepatitis a vaccine.
    Ambrosch F; Finkel B; Herzog C; Koren A; Kollaritsch H
    Infection; 2004 Jun; 32(3):149-52. PubMed ID: 15188074
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term immunogenicity and immune memory after two doses of the adult formulation of a combined hepatitis A and B vaccine in children 1 to 11 years of age.
    van Damme P; Kafeja F; Van Der Wielen M; Leyssen M; Jacquet JM
    Pediatr Infect Dis J; 2011 Aug; 30(8):703-5. PubMed ID: 21346683
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunogenicity and safety of a virosomal hepatitis A vaccine (Epaxal) in the elderly.
    D'Acremont V; Herzog C; Genton B
    J Travel Med; 2006; 13(2):78-83. PubMed ID: 16553593
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Kinetics of maternally acquired anti-hepatitis A antibodies: prediction of waning based on maternal or cord blood antibody levels.
    Brinkhof MW; Mayorga O; Bock J; Heininger U; Herzog C
    Vaccine; 2013 Mar; 31(11):1490-5. PubMed ID: 23328312
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immune responses of anti-HAV in children vaccinated with live attenuated and inactivated hepatitis A vaccines.
    Wang XY; Xu Z; Yao X; Tian M; Zhou L; He L; Wen Y
    Vaccine; 2004 May; 22(15-16):1941-5. PubMed ID: 15121306
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of immunogenicity between inactivated and live attenuated hepatitis A vaccines: a single-blind, randomized, parallel-group clinical trial among children in Xinjiang Uighur Autonomous Region, China.
    Liu XE; Wushouer F; Gou A; Kuerban M; Li X; Sun Y; Zhang J; Liu Y; Li J; Zhuang H
    Hum Vaccin Immunother; 2013 Jul; 9(7):1460-5. PubMed ID: 23571173
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Persistence of seroprotection 10 years after primary hepatitis A vaccination in an unselected study population.
    Rendi-Wagner P; Korinek M; Winkler B; Kundi M; Kollaritsch H; Wiedermann U
    Vaccine; 2007 Jan; 25(5):927-31. PubMed ID: 17005304
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunogenicity and safety of live attenuated hepatitis A vaccine: a multicentric study.
    Faridi MM; Shah N; Ghosh TK; Sankaranarayanan VS; Arankalle V; Aggarwal A; Sathiyasekaran M; Bhattacharya N; Vasanthi T; Chatterjee S; Choudhury J; Mitra M
    Indian Pediatr; 2009 Jan; 46(1):29-34. PubMed ID: 19179715
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interchangeability and tolerability of two inactivated hepatitis A vaccines in Chinese children.
    Zhang ZL; Zhu XJ; Wang X; Liang M; Sun J; Liu Y; Gao ZG; Wu JY; Dong XJ; Liu RK; Chen JT; Zhang YQ; Wang W; Zhang LP; Yin W
    Vaccine; 2012 Jun; 30(27):4028-33. PubMed ID: 22537990
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Seven-year follow-up of the immune response after one or 2 doses of inactivated hepatitis A vaccine given at 1 year of age in the Mendoza Province of Argentina.
    Espul C; Benedetti L; Linares M; Cuello H; Lo Castro I; Thollot Y; Rasuli A
    Hum Vaccin Immunother; 2017 Nov; 13(11):2707-2712. PubMed ID: 28933624
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of immunogenicity and persistence between inactivated hepatitis A vaccine Healive® and Havrix® among children: A 5-year follow-up study.
    Yu C; Song Y; Qi Y; Li C; Jiang Z; Li C; Zhang W; Wang L; Xia J
    Hum Vaccin Immunother; 2016 Oct; 12(10):2595-2602. PubMed ID: 27385349
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antibody persistence and booster vaccination during the second and fifth years of life in a cohort of children who were born prematurely.
    Omeñaca F; Garcia-Sicilia J; Boceta R; Sistiaga-Hernando A; García-Corbeira P
    Pediatr Infect Dis J; 2007 Sep; 26(9):824-9. PubMed ID: 17721379
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Influence of maternal antibody against hepatitis B surface antigen on active immune response to hepatitis B vaccine in infants.
    Hu Y; Wu Q; Xu B; Zhou Z; Wang Z; Zhou YH
    Vaccine; 2008 Nov; 26(48):6064-7. PubMed ID: 18812198
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Immunogenicity and long-term persistence of anti-HAV in groups with different attenuated and inactived hepatitis A vaccine dosage].
    Wang X; Ma J; Zhang Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2001 Apr; 22(2):111-3. PubMed ID: 11860857
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Decline of maternal hepatitis A virus antibody levels in infants.
    De Silvestri A; Avanzini MA; Terulla V; Zucca S; Polatti F; Belloni C
    Acta Paediatr; 2002; 91(8):882-4. PubMed ID: 12222709
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Passive acquired immunity against measles in infants born to naturally infected and vaccinated mothers.
    Szenborn L; Tischer A; Pejcz J; Rudkowski Z; Wójcik M
    Med Sci Monit; 2003 Dec; 9(12):CR541-6. PubMed ID: 14646978
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of inactivated hepatitis A vaccine in Canadians 40 years of age or more.
    Scheifele DW; Bjornson GJ
    CMAJ; 1993 Feb; 148(4):551-5. PubMed ID: 8431816
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunogenicity, reactogenicity and adherence to a combined hepatitis A and B vaccine in illicit drug users.
    Lugoboni F; Quaglio G; Pajusco B; Civitelli P; Romanò L; Bossi C; Spilimbergo I; Mezzelani P
    Addiction; 2004 Dec; 99(12):1560-4. PubMed ID: 15585047
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunogenicity and safety of an inactivated hepatitis a vaccine administered concomitantly with a pneumococcal conjugate vaccine in healthy children 15 months of age.
    Trofa AF; Levin M; Marchant CD; Hedrick J; Blatter MM
    Pediatr Infect Dis J; 2008 Jul; 27(7):658-60. PubMed ID: 18536623
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunogenicity and safety of a pediatric dose virosomal hepatitis A vaccine in Thai HIV-infected children.
    Saksawad R; Likitnukul S; Warachit B; Hanvivatvong O; Poovorawan Y; Puripokai P
    Vaccine; 2011 Jun; 29(29-30):4735-8. PubMed ID: 21570433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.